MedPath
NMPA Approval

Rilpivirine Tablets

国药准字H20244829

September 3, 2024

Drug Information

利匹韦林片

片剂

25mg(以利匹韦林计)

化学药品

September 3, 2024

Company Information

Applicant Company

安徽省合肥市高新技术开发区红枫路30号

Manufacturing Company

合肥市高新技术开发区红枫路30号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利匹韦林片 - NMPA 批准文号 | MedPath